# Synthesis of Kojic Ester Derivatives as Potential Antibacterial Agent

Authors: Carolynne Zie Wei Sie; Zainab Ngaini; Nurashikin Suhaili; Eswaran Madiahlagan
Journal: Journal of Chemistry
 (2018)

---

## Abstract

The search for lead product with beneficial pharmacological properties has become a great challenge and costly. Extraction and synthetic modification of bioactive compounds from natural resources has gained great attention and is cost effective. In this study, kojic acid was produced from fungal fermentation, using sago waste as substrate, and chemically incorporated with chalcones and azobenzene to form a series of kojic ester derivatives and evaluated for antibacterial activities. Kojic ester bearing halogenated chalcone demonstrated active inhibition againstStaphylococcus aureus compared to that of standard ampicillin. The inhibition increased as the electronegativity of halogens decreased, while incorporation of azobenzene derivatives on kojic acid backbone demonstrated fair antibacterial activity againstEscherichia coliwith minimum inhibitory concentration (MIC) of 190–330 ppm. The presence of C=C and N=N reactive moieties in both chalcone and azo molecules contributed to the potential biological activities of the kojic acid ester.


---

## Body

## 1. Introduction

Kojic acid is a natural pyrone produced from fungal fermentation from various types of carbon substrates in the presence of fungi [1, 2]. Kojic acid and its derivatives have drawn attention and were studied intensively due to its significant biological activities in medicine and pharmacological field such as antifungal, antibiotic [3, 4], anti-inflammatory and analgesic [5], and antibacterial [6] properties.Many recent studies reported on chemical modification of kojic acid for various applications such as antibacterial activity [7] and dye sensitized solar cell (DSSC) [8]. Synthesis of bioactive molecules employing kojic acid as a precursor via esterification of available hydroxyl groups has been widely reported to overcome the drawbacks of its hydrophilic properties in various applications [9–12]. Esterification of kojic acid, for instance, is able to enhance the hydrophobic properties which in turn improved its performance as tyrosinase inhibitor and antioxidant [13, 14].Incorporation of kojic acid into other biological active compounds has also been reported with enhanced biological activities [15, 16]. Chalcones are an example of biological active compound which is derived from natural sources such as fruits, vegetables, spices, tea, and soy-based foodstuff [17, 18] and used as an intermediate precursor of flavonoids and isoflavonoids [19]. Chalcone is also commonly prepared via Claisen Schmidt condensation. The synthesis of chalcone has drawn much attentions due to the presence of its α,β-unsaturated ketone moieties which contributes to various biological activities such as antimalaria [20], anticancer [21], antiprotozoal, anti-inflammatory, antibacterial, antifilarial, anticonvulsant [22], antifungal, insect antifeedant, antimutagenic [23], and antioxidant [24, 25]. The presence of halogen substituents particularly at thepara position of chalcone backbone has been reported with excellent biological activities such as antibacterial [26] and anti-inflammatory [27], while azobenzene bearing aryl/alkyl and N=N reactive moieties have been extensively reported due to its excellent antibacterial [28, 29], antioxidant [30], anti-inflammatory [31], antifungal [32], and antitumor [33] properties. Azobenzene is also recognized for its medicinal properties such as antineoplastic [34], antidiabetic [35], and antiseptic [36].Herein, we report on the isolation of kojic acid from sago waste and utilized it as a precursor for the synthesis of kojic acid ester bearing chalcone3a–c and azobenzene5a–d moieties. These compounds were screened for potential antibacterial activities againstE. coli andS. aureus, and the effect of different moieties towards biological activities of kojic acid was studied.


## 2. Experimental

All the reagents were used as received without any further purification. Melting points were determined in open capillary tubes and are uncorrected. The IR spectra were recorded with KBr on Perkin Elmer 1605 FTIR spectrophotometer. The1H NMR were recorded in CDCl3 or DMSO-d6 on JEOL ECA 500 spectrometer at 500 MHz using TMS as internal standard. The elemental carbon hydrogen nitrogen sulphur (CHNS) elemental analyses were performed using Thermo Scientific™ FLASH 2000 CHNS/O Analyzer.


### 2.1. Fermentation of Kojic Acid (1)

Sago waste was used as the substrate for kojic acid fermentation. Prior to fermentation, sago waste (5 g) was dried, ground, and sieved. The medium was supplemented with 3% (w/v) urea and 10% (w/v) mineral salts solution containing KH2PO4, (w/v) MgSO4·7H2O, and yeast extract. Mixed strains ofAspergillus flavus NSH9 andA. flavus Link 44-1 were added for fermentation process. The culture was incubated at 30±2°C in static condition for 20 days. The slurry suspension culture (40 mL) was extracted with ethyl acetate (2 × 15 mL). The organic layer was evaporated in vacuo to form crude brown solid and recrystallized from ethanol to afford1 (0.15 g, 30%) as a yellowish needle like solid; m.p. 149-150°C [Reported 151–154°C [37]]; νmax (KBr/cm−1) 3173 (OH), 2919 (C=C), 1661 (C=O), 1228 (C-O); 1H NMR (500 MHz, DMSO-d6): δ 9.04 (1H, s, OH-5), 8.02 (s, 1H, H-6), 6.34 (1H, s, H-3), 5.67 (1H, s, OH-7), 4.29 (1H, s, H-7); 13C NMR (125 MHz, DMSO-d6): δ 174.4 (C-4), 168.6 (C-2), 146.2 (C-5), 139.8 (C-6), 110.4 (C-3), 60.0 (C-7).


### 2.2. General Method for Synthesis of 4-Carboxyl Chalcone (2a–c)

Acetophenone (1.2 g, 0.1 mmol) was added to 4-carboxybenzaldehyde derivatives (0.15 g, 0.1 mmol) in methanol (50 mL). KOH (1.7 g, 0.3 mmol) in methanol was added and the mixture was stirred at room temperature for 4 h under nitrogen atmosphere. The precipitate formed was filtered and recrystalized from ethanol to afford title compound.4-[(E)-3-Oxo-3-phenyl-prop-1-enyl]benzoic Acid (2a).Compound2a (2.32 g, 92%) as a yellowish powder. m.p. 223-224°C; (Found: C, 76.61; H, 4.37%. C16H12O3 Requires C, 76.2; H, 4.8%); νmax (KBr/cm−1) 3059 (C=CH), 1677 (C=O), 1608 (COO), 1578 (aromatic); 1H NMR (500 MHz, DMSO-d6): δ 8.17 (2H, d, J = 7.45 Hz, H-3), 8.05 (1H, d, J = 16.05 Hz, H-β), 8.02 (2H, d, J = 8.06 Hz, H-8), 7.99 (2H, d, J = 8.00 Hz, H-2), 7.78 (1H, d, J = 15.45 Hz, H-α); 7.69 (1H, t, J = 7.73 Hz, H-10), 7.59 (2H, t, J = 7.75 Hz, H-9).4-[(E)-3-(4-Bromophenyl)-3-oxo-prop-1-enyl]benzoic Acid (2b).Compound2b (2.65 g, 88%) as a yellowish powder; m.p. 246-247°C; (Found: C, 58.44; H, 3.65%. C16H11BrO3 Requires C, 58.0; H, 3.3%); νmax (KBr/cm−1) 3064 (C=CH), 1663 (C=O), 1607 (COO), 1583 (aromatic); 1H NMR (500 MHz, DMSO-d6): δ 8.13 (2H, d, J = 8.00 Hz, H-8), 8.05 (1H, d, J = 15.45 Hz, H-β), 8.02 (2H, d, J = 8.00 Hz, H-3), 7.98 (2H, d, J = 8.60 Hz, H-9), 7.79 (1H, d, J = 15.45 Hz, H-α), 7.79 (2H, d, J = 8.00 Hz, H-2).4-[(E)-3-(4-Chlorophenyl)-3-oxo-prop-1-enyl]benzoic Acid (2c).Compound2c (2.12 g, 74%) as a yellowish powder. m.p. 259-260°C; (Found: C, 67.09; H, 3.27%. C16H11ClO3 Requires C, 67.0; H, 3.9%); νmax (KBr/cm−1) 2943 (C=CH), 1678 (C=O), 1612 (COO), 1577 (aromatic); 1H NMR (500 MHz, DMSO-d6): δ 8.20 (2H, d, J = 8.40 Hz, H-8), 8.00 (1H, d, J = 16.05 Hz, H-β), 7.93 (2H, d, J = 8.40 Hz, H-3), 7.90 (2H, d, J = 8.40 Hz, H-9), 7.78 (1H, d, J = 16.05 Hz, H-α), 7.65 (2H, d, J = 7.65 Hz, H-2).


### 2.3. General Method for Synthesis of Kojic Acid-Chalcone Derivatives (3a–c)

Chalcone2a–c (1.26 g, 0.05 mmol) was added to a solution of1 (0.71 g, 0.05 mmol), DMAP (0.12 g, 1 mmol), and DCC (1.03 g, 0.05 mmol) in DCM (30 mL). The reaction mixture was stirred at 0°C for 4 h, washed with acetic acid (1 M, 2 × 20 mL), followed by Na2CO3 solution (1 M, 2 × 20 mL), and dried over magnesium sulphate. The crude product obtained was purified by column chromatography over silica gel (eluting with 1 : 2 EA/Hex) to afford title compound.[6-(Hydroxymethyl)-4-oxo-pyran-3-yl] 4-[(E)-3-oxo-3-phenyl-prop-1-enyl] Benzoate (3a).Compound3a (0.4 g, 23%) as a white powder. m.p. 162-163°C; (Found: C, 69.56; H, 4.25%. C22H16O6 Requires C, 70.2; H, 4.3%); νmax (KBr/cm−1) 2987 (C=CH), 1730 (C=O ester), 1665 (C=O), 1644 (C=O), 1605 (aromatic), 1201 (C-O); 1H NMR (500 MHz, DMSO-d6): δ 8.69 (1H, s, H-6), 8.11 (7H, m, H-9, H-10, H-15, H-β), 7.79 (2H, d, J = 16.05 Hz, H-α), 7.67 (1H, m, H-17), 7.59 (2H, m, H-16), 6.65 (1H, s, H-3), 5.02 (2H, s, H-7).[6-(Hydroxymethyl)-4-oxo-pyran-3-yl]4-[(E)-3-(4-bromophenyl)-3-oxo-prop-1-enyl] Benzoate (3b).Compound3b (0.4 g, 19%) as a white powder. m.p. 194-195°C; (Found: C, 58.37; H, 3.24%. C22H15BrO6 Requires C, 58.0; H, 3.3%); νmax (KBr/cm−1) 2926 (C=CH), 1697 (C=O ester), 1651 (C=O), 1623 (C=O), 1570 (aromatic), 1242 (C-O); 1H NMR (500 MHz, DMSO-d6): δ 8.67 (1H, s, H-6), 8.13 (2H, d, J = 8.6 Hz, H-15), 8.12 (2H, d, J 8.00 Hz, H-10), 8.04 (1H, d, J = 15.45 Hz, H-β), 7.99 (2H, d, J = 8.00 Hz, H-16), 8.00 (1H, d, J = 12.6 Hz, H-α), 7.80 (2H, d, J = 8.55 Hz, H-9), 6.50 (1H, s, H-3), 4.40 (2H, s, H-7).[6-(Hydroxymethyl)-4-oxo-pyran-3-yl]4-[(E)-3-(4-chlorophenyl)-3-oxo-prop-1-enyl]benzoate (3c).Compound3c (0.5 g, 25%) as a white powder. m.p. 202-203°C; (Found: C, 63.54; H, 3.31%. C22H15ClO6 Requires C, 64.3; H, 3.7%); νmax (KBr/cm−1) 2927 (C=CH), 1731 (C=O ester), 1666 (C=O), 1643 (C=O), 1607 (aromatic), 1239 (C-O); 1H NMR (500 MHz, DMSO-d6): δ 8.67 (1H, s, H-6), 8.13 (4H, t, J = 7.73 Hz, H-15, H-10), 8.04 (1H, d, J = 14.9 Hz, H-β), 7.99 (2H, d, J = 8.0 Hz, H-16), 7.86 (1H, d, J = 11.45 Hz, H-α), 7.79 (2H, d, J = 7.45 Hz, H-9), 6.50 (1H, s, H-3), 4.39 (2H, s, H-7).


### 2.4. Synthesis of Azobenzene Derivatives (4a–d)

HCl (8 M, 100 mL) was added drop wise to a solution of 4-aminoethylbenzoate (5 g, 30.0 mmol) in methanol (50 mL) in an ice bath at 0–5°C. Sodium nitrite (3.1 g, 45.0 mmol) in distilled water (10 mL) and phenol (3.4 g, 36 mmol) in methanol (50 mL) were added drop wise to the reaction mixture. NaOH solution (1 M, 100 mL) was then added drop wise to pH 8.5–9.5. The reaction mixture was stirred for 4 hr under nitrogen atmosphere. Methanol (50 mL) was added and acidified with HCl (8 M, 50 mL) to form precipitate. The solid was filtered, washed, and recrystallized from ethanol. KOH (0.13 g, 2.4 mmol) was added to the solid (0.2 g, 0.8 mmol) in methanol (50 mL) and heated under reflux for 4 h under nitrogen atmosphere. Cold water (30 mL) was added to the reaction mixture, acidified with acetic acid (8 M), and filtered and recrystallized from ethanol to give azobenzene intermediate. Azobenzene (1.5 g, 5 mmol) was added to a solution of bromoalkene derivatives, t- BuOK (0.62 g, 5.0 mmol) and KI (20 mg) in acetone (100 mL), and heated at reflux for 48 h under nitrogen atmosphere. DCM (50 mL) and water (30 mL) were added and the layers were separated. The aqueous layer was extracted with DCM (2 × 30 mL) and the combined organic layers were dried and evaporated under reduced pressure and recrystallized from ethanol to give title compound4a–d as colorless crystals. FTIR and NMR data were consistent with the reported literature [8].


### 2.5. Synthesis of Kojic Acid-Azobenzene (5a–d)

Thionyl chloride (0.036 g, 0.3 mmol) was added to a solution of1 (0.014 g, 0.1 mmol) in DMF (20 mL) and heated under reflux for 4 h. The reaction mixture was extracted with DCM (2 × 15 mL). The organic layer was dried, filtered, and concentrated under reduced pressure to give kojyl chloride as yellowish needle solid (0.012 g, 70%). Azo intermediate was added to a solution of kojyl chloride prepared (0.1 g, 0.6 mmol) in DMF (30 mL) with TEA (0.015 g, 0.15 mmol) in dried acetone (20 mL) and heated under refluxed for 24 h. The reaction mixture was washed with dilute HCl (1 M, 2 × 20 mL). The organic layer was dried, filtered, and concentrated under reduced pressure. Crude product was recrystallized from ethanol to afford5b–e as colorless crystals. FTIR and NMR data were consistent with the reported literature [8].


### 2.6. Antibacterial Screening

#### 2.6.1. Turbidimetric Kinetic Method

The antibacterial activities of synthesized4a–d and5a–d were screened againstEscherichia coliusing turbidimetric kinetic method.Escherichia coliwere cultured on LB plate agar for 24 h at 37°C and a single colony was transferred to the media containing nutrient broth prepared. The inoculum was allowed to grow at 37°C with 250 rpm stirring overnight. Inoculum (0.2 mL) was added to 10 mL of culture medium which had been added with different concentrations (50 ppm, 80 ppm, and 100 ppm) of respective compounds in DMSO. Three replicates of each concentration were prepared. The control used was the medium broth of inoculums added with DMSO with no active compound. The mixture was shaken at 230 rpm at 37°C. The transmittances (T) of the aliquots were taken every 1 h interval for six continuous hours using UV-Visible Spectrophotometer Optima SP-300. The antibacterial activity was determined from the graph of In Nt versus time plotted. The In Nt values represent the number of colony forming units (units/mL) which follows the equation of In Nt = 27.1 − 8.56 T [38, 39]


#### 2.6.2. Via Kirby Bauer Disc Diffusion Method

The antibacterial activities of the synthesized2a–c and3a–c were evaluated againstEscherichia coli andStaphylococcus aureus using Kirby Bauer Disc Diffusion method.E. coli andS. aureus were used as inoculums and cultured in Mueller-Hinton Broth (MHB) and incubated at 37.5°C with constant shaking at 150 rpm for 18 h. The bacteria suspension prepared was inoculated onto the entire surface of a Mueller-Hinton Agar (MHA) plate with sterilised cotton tipped swab to form an even lawn. Sterilised filter paper disc impregnated with 10 μL of the compound in DMSO was placed on the bacteria surface of MHA plate using a sterilised forcep. The plates were incubated at 37.5°C for 24 h. The zone of inhibition was measured in millimetres (mm) to estimate the potency of the tested compound.


## 2.1. Fermentation of Kojic Acid (1)

Sago waste was used as the substrate for kojic acid fermentation. Prior to fermentation, sago waste (5 g) was dried, ground, and sieved. The medium was supplemented with 3% (w/v) urea and 10% (w/v) mineral salts solution containing KH2PO4, (w/v) MgSO4·7H2O, and yeast extract. Mixed strains ofAspergillus flavus NSH9 andA. flavus Link 44-1 were added for fermentation process. The culture was incubated at 30±2°C in static condition for 20 days. The slurry suspension culture (40 mL) was extracted with ethyl acetate (2 × 15 mL). The organic layer was evaporated in vacuo to form crude brown solid and recrystallized from ethanol to afford1 (0.15 g, 30%) as a yellowish needle like solid; m.p. 149-150°C [Reported 151–154°C [37]]; νmax (KBr/cm−1) 3173 (OH), 2919 (C=C), 1661 (C=O), 1228 (C-O); 1H NMR (500 MHz, DMSO-d6): δ 9.04 (1H, s, OH-5), 8.02 (s, 1H, H-6), 6.34 (1H, s, H-3), 5.67 (1H, s, OH-7), 4.29 (1H, s, H-7); 13C NMR (125 MHz, DMSO-d6): δ 174.4 (C-4), 168.6 (C-2), 146.2 (C-5), 139.8 (C-6), 110.4 (C-3), 60.0 (C-7).


## 2.2. General Method for Synthesis of 4-Carboxyl Chalcone (2a–c)

Acetophenone (1.2 g, 0.1 mmol) was added to 4-carboxybenzaldehyde derivatives (0.15 g, 0.1 mmol) in methanol (50 mL). KOH (1.7 g, 0.3 mmol) in methanol was added and the mixture was stirred at room temperature for 4 h under nitrogen atmosphere. The precipitate formed was filtered and recrystalized from ethanol to afford title compound.4-[(E)-3-Oxo-3-phenyl-prop-1-enyl]benzoic Acid (2a).Compound2a (2.32 g, 92%) as a yellowish powder. m.p. 223-224°C; (Found: C, 76.61; H, 4.37%. C16H12O3 Requires C, 76.2; H, 4.8%); νmax (KBr/cm−1) 3059 (C=CH), 1677 (C=O), 1608 (COO), 1578 (aromatic); 1H NMR (500 MHz, DMSO-d6): δ 8.17 (2H, d, J = 7.45 Hz, H-3), 8.05 (1H, d, J = 16.05 Hz, H-β), 8.02 (2H, d, J = 8.06 Hz, H-8), 7.99 (2H, d, J = 8.00 Hz, H-2), 7.78 (1H, d, J = 15.45 Hz, H-α); 7.69 (1H, t, J = 7.73 Hz, H-10), 7.59 (2H, t, J = 7.75 Hz, H-9).4-[(E)-3-(4-Bromophenyl)-3-oxo-prop-1-enyl]benzoic Acid (2b).Compound2b (2.65 g, 88%) as a yellowish powder; m.p. 246-247°C; (Found: C, 58.44; H, 3.65%. C16H11BrO3 Requires C, 58.0; H, 3.3%); νmax (KBr/cm−1) 3064 (C=CH), 1663 (C=O), 1607 (COO), 1583 (aromatic); 1H NMR (500 MHz, DMSO-d6): δ 8.13 (2H, d, J = 8.00 Hz, H-8), 8.05 (1H, d, J = 15.45 Hz, H-β), 8.02 (2H, d, J = 8.00 Hz, H-3), 7.98 (2H, d, J = 8.60 Hz, H-9), 7.79 (1H, d, J = 15.45 Hz, H-α), 7.79 (2H, d, J = 8.00 Hz, H-2).4-[(E)-3-(4-Chlorophenyl)-3-oxo-prop-1-enyl]benzoic Acid (2c).Compound2c (2.12 g, 74%) as a yellowish powder. m.p. 259-260°C; (Found: C, 67.09; H, 3.27%. C16H11ClO3 Requires C, 67.0; H, 3.9%); νmax (KBr/cm−1) 2943 (C=CH), 1678 (C=O), 1612 (COO), 1577 (aromatic); 1H NMR (500 MHz, DMSO-d6): δ 8.20 (2H, d, J = 8.40 Hz, H-8), 8.00 (1H, d, J = 16.05 Hz, H-β), 7.93 (2H, d, J = 8.40 Hz, H-3), 7.90 (2H, d, J = 8.40 Hz, H-9), 7.78 (1H, d, J = 16.05 Hz, H-α), 7.65 (2H, d, J = 7.65 Hz, H-2).


## 2.3. General Method for Synthesis of Kojic Acid-Chalcone Derivatives (3a–c)

Chalcone2a–c (1.26 g, 0.05 mmol) was added to a solution of1 (0.71 g, 0.05 mmol), DMAP (0.12 g, 1 mmol), and DCC (1.03 g, 0.05 mmol) in DCM (30 mL). The reaction mixture was stirred at 0°C for 4 h, washed with acetic acid (1 M, 2 × 20 mL), followed by Na2CO3 solution (1 M, 2 × 20 mL), and dried over magnesium sulphate. The crude product obtained was purified by column chromatography over silica gel (eluting with 1 : 2 EA/Hex) to afford title compound.[6-(Hydroxymethyl)-4-oxo-pyran-3-yl] 4-[(E)-3-oxo-3-phenyl-prop-1-enyl] Benzoate (3a).Compound3a (0.4 g, 23%) as a white powder. m.p. 162-163°C; (Found: C, 69.56; H, 4.25%. C22H16O6 Requires C, 70.2; H, 4.3%); νmax (KBr/cm−1) 2987 (C=CH), 1730 (C=O ester), 1665 (C=O), 1644 (C=O), 1605 (aromatic), 1201 (C-O); 1H NMR (500 MHz, DMSO-d6): δ 8.69 (1H, s, H-6), 8.11 (7H, m, H-9, H-10, H-15, H-β), 7.79 (2H, d, J = 16.05 Hz, H-α), 7.67 (1H, m, H-17), 7.59 (2H, m, H-16), 6.65 (1H, s, H-3), 5.02 (2H, s, H-7).[6-(Hydroxymethyl)-4-oxo-pyran-3-yl]4-[(E)-3-(4-bromophenyl)-3-oxo-prop-1-enyl] Benzoate (3b).Compound3b (0.4 g, 19%) as a white powder. m.p. 194-195°C; (Found: C, 58.37; H, 3.24%. C22H15BrO6 Requires C, 58.0; H, 3.3%); νmax (KBr/cm−1) 2926 (C=CH), 1697 (C=O ester), 1651 (C=O), 1623 (C=O), 1570 (aromatic), 1242 (C-O); 1H NMR (500 MHz, DMSO-d6): δ 8.67 (1H, s, H-6), 8.13 (2H, d, J = 8.6 Hz, H-15), 8.12 (2H, d, J 8.00 Hz, H-10), 8.04 (1H, d, J = 15.45 Hz, H-β), 7.99 (2H, d, J = 8.00 Hz, H-16), 8.00 (1H, d, J = 12.6 Hz, H-α), 7.80 (2H, d, J = 8.55 Hz, H-9), 6.50 (1H, s, H-3), 4.40 (2H, s, H-7).[6-(Hydroxymethyl)-4-oxo-pyran-3-yl]4-[(E)-3-(4-chlorophenyl)-3-oxo-prop-1-enyl]benzoate (3c).Compound3c (0.5 g, 25%) as a white powder. m.p. 202-203°C; (Found: C, 63.54; H, 3.31%. C22H15ClO6 Requires C, 64.3; H, 3.7%); νmax (KBr/cm−1) 2927 (C=CH), 1731 (C=O ester), 1666 (C=O), 1643 (C=O), 1607 (aromatic), 1239 (C-O); 1H NMR (500 MHz, DMSO-d6): δ 8.67 (1H, s, H-6), 8.13 (4H, t, J = 7.73 Hz, H-15, H-10), 8.04 (1H, d, J = 14.9 Hz, H-β), 7.99 (2H, d, J = 8.0 Hz, H-16), 7.86 (1H, d, J = 11.45 Hz, H-α), 7.79 (2H, d, J = 7.45 Hz, H-9), 6.50 (1H, s, H-3), 4.39 (2H, s, H-7).


## 2.4. Synthesis of Azobenzene Derivatives (4a–d)

HCl (8 M, 100 mL) was added drop wise to a solution of 4-aminoethylbenzoate (5 g, 30.0 mmol) in methanol (50 mL) in an ice bath at 0–5°C. Sodium nitrite (3.1 g, 45.0 mmol) in distilled water (10 mL) and phenol (3.4 g, 36 mmol) in methanol (50 mL) were added drop wise to the reaction mixture. NaOH solution (1 M, 100 mL) was then added drop wise to pH 8.5–9.5. The reaction mixture was stirred for 4 hr under nitrogen atmosphere. Methanol (50 mL) was added and acidified with HCl (8 M, 50 mL) to form precipitate. The solid was filtered, washed, and recrystallized from ethanol. KOH (0.13 g, 2.4 mmol) was added to the solid (0.2 g, 0.8 mmol) in methanol (50 mL) and heated under reflux for 4 h under nitrogen atmosphere. Cold water (30 mL) was added to the reaction mixture, acidified with acetic acid (8 M), and filtered and recrystallized from ethanol to give azobenzene intermediate. Azobenzene (1.5 g, 5 mmol) was added to a solution of bromoalkene derivatives, t- BuOK (0.62 g, 5.0 mmol) and KI (20 mg) in acetone (100 mL), and heated at reflux for 48 h under nitrogen atmosphere. DCM (50 mL) and water (30 mL) were added and the layers were separated. The aqueous layer was extracted with DCM (2 × 30 mL) and the combined organic layers were dried and evaporated under reduced pressure and recrystallized from ethanol to give title compound4a–d as colorless crystals. FTIR and NMR data were consistent with the reported literature [8].


## 2.5. Synthesis of Kojic Acid-Azobenzene (5a–d)

Thionyl chloride (0.036 g, 0.3 mmol) was added to a solution of1 (0.014 g, 0.1 mmol) in DMF (20 mL) and heated under reflux for 4 h. The reaction mixture was extracted with DCM (2 × 15 mL). The organic layer was dried, filtered, and concentrated under reduced pressure to give kojyl chloride as yellowish needle solid (0.012 g, 70%). Azo intermediate was added to a solution of kojyl chloride prepared (0.1 g, 0.6 mmol) in DMF (30 mL) with TEA (0.015 g, 0.15 mmol) in dried acetone (20 mL) and heated under refluxed for 24 h. The reaction mixture was washed with dilute HCl (1 M, 2 × 20 mL). The organic layer was dried, filtered, and concentrated under reduced pressure. Crude product was recrystallized from ethanol to afford5b–e as colorless crystals. FTIR and NMR data were consistent with the reported literature [8].


## 2.6. Antibacterial Screening

### 2.6.1. Turbidimetric Kinetic Method

The antibacterial activities of synthesized4a–d and5a–d were screened againstEscherichia coliusing turbidimetric kinetic method.Escherichia coliwere cultured on LB plate agar for 24 h at 37°C and a single colony was transferred to the media containing nutrient broth prepared. The inoculum was allowed to grow at 37°C with 250 rpm stirring overnight. Inoculum (0.2 mL) was added to 10 mL of culture medium which had been added with different concentrations (50 ppm, 80 ppm, and 100 ppm) of respective compounds in DMSO. Three replicates of each concentration were prepared. The control used was the medium broth of inoculums added with DMSO with no active compound. The mixture was shaken at 230 rpm at 37°C. The transmittances (T) of the aliquots were taken every 1 h interval for six continuous hours using UV-Visible Spectrophotometer Optima SP-300. The antibacterial activity was determined from the graph of In Nt versus time plotted. The In Nt values represent the number of colony forming units (units/mL) which follows the equation of In Nt = 27.1 − 8.56 T [38, 39]


### 2.6.2. Via Kirby Bauer Disc Diffusion Method

The antibacterial activities of the synthesized2a–c and3a–c were evaluated againstEscherichia coli andStaphylococcus aureus using Kirby Bauer Disc Diffusion method.E. coli andS. aureus were used as inoculums and cultured in Mueller-Hinton Broth (MHB) and incubated at 37.5°C with constant shaking at 150 rpm for 18 h. The bacteria suspension prepared was inoculated onto the entire surface of a Mueller-Hinton Agar (MHA) plate with sterilised cotton tipped swab to form an even lawn. Sterilised filter paper disc impregnated with 10 μL of the compound in DMSO was placed on the bacteria surface of MHA plate using a sterilised forcep. The plates were incubated at 37.5°C for 24 h. The zone of inhibition was measured in millimetres (mm) to estimate the potency of the tested compound.


## 2.6.1. Turbidimetric Kinetic Method

The antibacterial activities of synthesized4a–d and5a–d were screened againstEscherichia coliusing turbidimetric kinetic method.Escherichia coliwere cultured on LB plate agar for 24 h at 37°C and a single colony was transferred to the media containing nutrient broth prepared. The inoculum was allowed to grow at 37°C with 250 rpm stirring overnight. Inoculum (0.2 mL) was added to 10 mL of culture medium which had been added with different concentrations (50 ppm, 80 ppm, and 100 ppm) of respective compounds in DMSO. Three replicates of each concentration were prepared. The control used was the medium broth of inoculums added with DMSO with no active compound. The mixture was shaken at 230 rpm at 37°C. The transmittances (T) of the aliquots were taken every 1 h interval for six continuous hours using UV-Visible Spectrophotometer Optima SP-300. The antibacterial activity was determined from the graph of In Nt versus time plotted. The In Nt values represent the number of colony forming units (units/mL) which follows the equation of In Nt = 27.1 − 8.56 T [38, 39]


## 2.6.2. Via Kirby Bauer Disc Diffusion Method

The antibacterial activities of the synthesized2a–c and3a–c were evaluated againstEscherichia coli andStaphylococcus aureus using Kirby Bauer Disc Diffusion method.E. coli andS. aureus were used as inoculums and cultured in Mueller-Hinton Broth (MHB) and incubated at 37.5°C with constant shaking at 150 rpm for 18 h. The bacteria suspension prepared was inoculated onto the entire surface of a Mueller-Hinton Agar (MHA) plate with sterilised cotton tipped swab to form an even lawn. Sterilised filter paper disc impregnated with 10 μL of the compound in DMSO was placed on the bacteria surface of MHA plate using a sterilised forcep. The plates were incubated at 37.5°C for 24 h. The zone of inhibition was measured in millimetres (mm) to estimate the potency of the tested compound.


## 3. Results and Discussion

### 3.1. Preparation of Kojic Acid via Fermentation

Kojic acid1 was prepared via fermentation of sago hampas employing mixed strains ofAspergillus flavus NSH9 andAspergillus flavus Link 44-1.Aspergillus flavus was used for a higher yield of1[15]. The optimum parameters were from a combination of 3% (w/v) urea and 10% mineral salts solution containing KH2PO4, (w/v) MgSO4·7H2O and yeast. KH2PO4 and MgSO4 supported the growth of bacteria strain and boosted the production of kojic acid [40]. Yeast is a nitrogen source for metabolic activation to enhance kojic acid production. Its high levels of essential components such as vitamins and oligoelements support growth of bacteria and fermentation process [3].


### 3.2. Synthesis of Kojic Acid Ester Derivatives

Kojic ester2a–c was prepared via Claisen Schmidt condensation followed by Steglich esterification with isolated kojic acid to yield3a–c, whereas kojic ester(5a–d) was prepared via kojyl chloride [11] followed by addition of4a–d to afford5a–d (70–87%). The overall synthesis is shown in Scheme 1. Structures of the compounds synthesized were confirmed by elemental analysis, IR spectra, and 1H NMR spectra.Scheme 1
Synthesis of kojic esters(3a–c) and(5a–d).The IR spectra for2a–c showed absorptions band at 3064–2943 cm−1 and 1678–1663 cm−1 attributed to C=C and C=O group of chalcone linkage. A sharp band at 1612–1607 cm−1 indicated the presence of carboxyl group. Absorption peaks at 1583–1577 cm−1 revealed the presence of aromatic group. The 1H NMR showed aromatic protons of2a at δ 8.17–7.59 ppm as doublet and triplet while aromatic protons of2b-c appeared at δ 8.20–7.65 ppm as four doublets with coupling constant 8–8.6 Hz. The peaks of CHα = CHβ were observed at δ 7.79–7.78 and 8.05–8.00 ppm as two doublets with Jab 15.5–16.1 Hz, which indicatedtrans configuration.Formation of3a–c was confirmed by FTIR and 1H NMR spectroscopies. The IR spectrum for3a–c showed appearance of C=O ester absorption band at 1731–1697 cm−1. The IR spectrum revealed two strong bands at 1666–1651 cm−1 and 1644–1623 cm−1 attributed to v(C=O) of chalcone and kojic acid, respectively. The absorption frequency at 1605–1570 cm−1 was attributed to aromatic group while ν(C-O) was represented by absorption band at 1242–1201 cm−1. The 1H NMR showed that all corresponding peaks indicated the formation of3a–c. The existence of kojic acid moieties in3a–c was proven by appearance of two kojic acid olefinic proton at δ 8.69–8.67 and 6.65–6.50 ppm as singlet. The oxymethyl protons of kojic acid were represented by peaks at δ 5.02–4.39 ppm.The NMR spectra of kojic ester (5a–d) via formation of kojyl chloride revealed the presence of peak attributed to oxymethyl proton (OCH2) at δ 5.26–5.24 ppm as singlet, which indicated 7-O-substituent1 [41]. In comparison to 5-O-substituted3a–c, 7-O-substituted5a–d showed shifted H-6 olefinic proton signals to upfield and oxymethyl proton signals to downfield. Carbonyl group of ketone is more deshielded than carbonyl group of ester due to deshielding effect of pyrone ring [42].


### 3.3. Antibacterial Activities of Kojic Ester Derivatives

The kojic ester derivatives3a–c and5a–d were evaluated for antibacterial activities against gram negative strainE. coliat 37°C via turbidimetric method at three different concentrations, 50 ppm, 80 ppm, and 100 ppm, and compared to chalcones (2a–c) and azobenzene (4a–d) derivatives. Due to solubility limitation of2a–c and3a–d in organic solvent, turbidimetric method was only applied on4a–d and5a–d. Negative control, which is comprised of solvent and inoculums, showed significant increase in growth ofE. coli. The antibacterial assay was expressed by plotting graph of In Nt versus time. The In Nt value indicated number of colony forming (growth ofE. coli) units/mL which followed the expression of In Nt = 27.1 − 8.56 T [39].Kojic ester4a–d exhibited weak inhibition while5a–d exhibited good inhibition againstE. coli. The inhibition of5a–d is concentration dependent where 100 ppm > 80 ppm > 50 ppm. The minimum inhibitory concentration (MIC) of4a–d and5a–d was determined by extrapolating the concentration to zero growth rate ofE. coli. The MIC of4a–d and5a–d is summarized in Table 1. Kojic ester moieties in azobenzene are envisaged to increase the lipophilic properties in5a–d to interact and destruct the bacterial cell membrane [43]. The presence of C=O and N=N moieties in kojic ester offers more reactive sites that easily protonated under acidic condition and reacted with the bacterial surfaces which further enhance the biological activity [44]. Compound5a-b showed better activity than5c-d due to the increase of chain length after the cutoff effect associated with decrease in solubility.Table 1
MIC for4a–d and 5a–d.
Compounds MIC (ppm) 4a >400 4b >400 4c >400 4d >400 5a 200 5b 190 5c 330 5d 330Antibacterial activity of kojic esters2a–c and3a–c bearing chalcone moieties was conducted by measuring the zone of inhibition on agar plates (Kirby Bauer Disc Diffusion method) againstS. aureusandE. colibacterial strain due to solubility limitation in DMSO. Ampicillin was used as reference standard and DMSO as negative control.The zone inhibition of2a–c and3a–c is shown in Table 2. Kojic acid showed no inhibition against bothS. aureus andE. coli, while both series of2a–c and3a–c showed no inhibition againstE. colicompared to standard ampicillin. Compounds2a–c and3a–c, however, showed active inhibition againstS. aureuswith2c and3a-b being inhibited better than ampicillin.The selective antibacterial activity of2a–c and3a–c against gram positive bacterial strain is due to the significance different in the membrane composition and architecture of gram positive and gram negative organism [45].S. aureus has simpler mesh like cell membrane compared toE. coli which eases the penetration of compound [46].Table 2
Inhibition zones of2a–c and 3a–c.
Compounds Zone of inhibition (mm) E. coli S. aureus 2a - 16.0 2b - 13.0 2c - 8.0 3a - 8.0 3b - 11.0 3c - 13.0 DMSO - - Kojic acid - - Ampicillin 16.0 11.0Antibacterial activities of2a–c increased with the decrease in electronegativity of substituent on chalcone. Electronegativity in decreasing order is as follows: Cl (8 mm) > Br (13 mm) > H (16 mm). Polarized ability of antibacterial agent increases with the decreased in electronegativity which reasoned to enhance activity of acting antibacterial agent [47].The antibacterial activities of3a–c, however, showed an opposite trend. The inhibition was increased with the increased in electronegativity. The incorporation of kojic acid transformed the lipophilic properties of the compound. A good balance between hydrophilic and hydrophobic properties of compound makes good antibacterial agent [48]. Compound3c with chlorine substituents showed the biggest zone of inhibition with 13 mm while3a with hydrogen showed the least zone of inhibition (8 mm).


## 3.1. Preparation of Kojic Acid via Fermentation

Kojic acid1 was prepared via fermentation of sago hampas employing mixed strains ofAspergillus flavus NSH9 andAspergillus flavus Link 44-1.Aspergillus flavus was used for a higher yield of1[15]. The optimum parameters were from a combination of 3% (w/v) urea and 10% mineral salts solution containing KH2PO4, (w/v) MgSO4·7H2O and yeast. KH2PO4 and MgSO4 supported the growth of bacteria strain and boosted the production of kojic acid [40]. Yeast is a nitrogen source for metabolic activation to enhance kojic acid production. Its high levels of essential components such as vitamins and oligoelements support growth of bacteria and fermentation process [3].


## 3.2. Synthesis of Kojic Acid Ester Derivatives

Kojic ester2a–c was prepared via Claisen Schmidt condensation followed by Steglich esterification with isolated kojic acid to yield3a–c, whereas kojic ester(5a–d) was prepared via kojyl chloride [11] followed by addition of4a–d to afford5a–d (70–87%). The overall synthesis is shown in Scheme 1. Structures of the compounds synthesized were confirmed by elemental analysis, IR spectra, and 1H NMR spectra.Scheme 1
Synthesis of kojic esters(3a–c) and(5a–d).The IR spectra for2a–c showed absorptions band at 3064–2943 cm−1 and 1678–1663 cm−1 attributed to C=C and C=O group of chalcone linkage. A sharp band at 1612–1607 cm−1 indicated the presence of carboxyl group. Absorption peaks at 1583–1577 cm−1 revealed the presence of aromatic group. The 1H NMR showed aromatic protons of2a at δ 8.17–7.59 ppm as doublet and triplet while aromatic protons of2b-c appeared at δ 8.20–7.65 ppm as four doublets with coupling constant 8–8.6 Hz. The peaks of CHα = CHβ were observed at δ 7.79–7.78 and 8.05–8.00 ppm as two doublets with Jab 15.5–16.1 Hz, which indicatedtrans configuration.Formation of3a–c was confirmed by FTIR and 1H NMR spectroscopies. The IR spectrum for3a–c showed appearance of C=O ester absorption band at 1731–1697 cm−1. The IR spectrum revealed two strong bands at 1666–1651 cm−1 and 1644–1623 cm−1 attributed to v(C=O) of chalcone and kojic acid, respectively. The absorption frequency at 1605–1570 cm−1 was attributed to aromatic group while ν(C-O) was represented by absorption band at 1242–1201 cm−1. The 1H NMR showed that all corresponding peaks indicated the formation of3a–c. The existence of kojic acid moieties in3a–c was proven by appearance of two kojic acid olefinic proton at δ 8.69–8.67 and 6.65–6.50 ppm as singlet. The oxymethyl protons of kojic acid were represented by peaks at δ 5.02–4.39 ppm.The NMR spectra of kojic ester (5a–d) via formation of kojyl chloride revealed the presence of peak attributed to oxymethyl proton (OCH2) at δ 5.26–5.24 ppm as singlet, which indicated 7-O-substituent1 [41]. In comparison to 5-O-substituted3a–c, 7-O-substituted5a–d showed shifted H-6 olefinic proton signals to upfield and oxymethyl proton signals to downfield. Carbonyl group of ketone is more deshielded than carbonyl group of ester due to deshielding effect of pyrone ring [42].


## 3.3. Antibacterial Activities of Kojic Ester Derivatives

The kojic ester derivatives3a–c and5a–d were evaluated for antibacterial activities against gram negative strainE. coliat 37°C via turbidimetric method at three different concentrations, 50 ppm, 80 ppm, and 100 ppm, and compared to chalcones (2a–c) and azobenzene (4a–d) derivatives. Due to solubility limitation of2a–c and3a–d in organic solvent, turbidimetric method was only applied on4a–d and5a–d. Negative control, which is comprised of solvent and inoculums, showed significant increase in growth ofE. coli. The antibacterial assay was expressed by plotting graph of In Nt versus time. The In Nt value indicated number of colony forming (growth ofE. coli) units/mL which followed the expression of In Nt = 27.1 − 8.56 T [39].Kojic ester4a–d exhibited weak inhibition while5a–d exhibited good inhibition againstE. coli. The inhibition of5a–d is concentration dependent where 100 ppm > 80 ppm > 50 ppm. The minimum inhibitory concentration (MIC) of4a–d and5a–d was determined by extrapolating the concentration to zero growth rate ofE. coli. The MIC of4a–d and5a–d is summarized in Table 1. Kojic ester moieties in azobenzene are envisaged to increase the lipophilic properties in5a–d to interact and destruct the bacterial cell membrane [43]. The presence of C=O and N=N moieties in kojic ester offers more reactive sites that easily protonated under acidic condition and reacted with the bacterial surfaces which further enhance the biological activity [44]. Compound5a-b showed better activity than5c-d due to the increase of chain length after the cutoff effect associated with decrease in solubility.Table 1
MIC for4a–d and 5a–d.
Compounds MIC (ppm) 4a >400 4b >400 4c >400 4d >400 5a 200 5b 190 5c 330 5d 330Antibacterial activity of kojic esters2a–c and3a–c bearing chalcone moieties was conducted by measuring the zone of inhibition on agar plates (Kirby Bauer Disc Diffusion method) againstS. aureusandE. colibacterial strain due to solubility limitation in DMSO. Ampicillin was used as reference standard and DMSO as negative control.The zone inhibition of2a–c and3a–c is shown in Table 2. Kojic acid showed no inhibition against bothS. aureus andE. coli, while both series of2a–c and3a–c showed no inhibition againstE. colicompared to standard ampicillin. Compounds2a–c and3a–c, however, showed active inhibition againstS. aureuswith2c and3a-b being inhibited better than ampicillin.The selective antibacterial activity of2a–c and3a–c against gram positive bacterial strain is due to the significance different in the membrane composition and architecture of gram positive and gram negative organism [45].S. aureus has simpler mesh like cell membrane compared toE. coli which eases the penetration of compound [46].Table 2
Inhibition zones of2a–c and 3a–c.
Compounds Zone of inhibition (mm) E. coli S. aureus 2a - 16.0 2b - 13.0 2c - 8.0 3a - 8.0 3b - 11.0 3c - 13.0 DMSO - - Kojic acid - - Ampicillin 16.0 11.0Antibacterial activities of2a–c increased with the decrease in electronegativity of substituent on chalcone. Electronegativity in decreasing order is as follows: Cl (8 mm) > Br (13 mm) > H (16 mm). Polarized ability of antibacterial agent increases with the decreased in electronegativity which reasoned to enhance activity of acting antibacterial agent [47].The antibacterial activities of3a–c, however, showed an opposite trend. The inhibition was increased with the increased in electronegativity. The incorporation of kojic acid transformed the lipophilic properties of the compound. A good balance between hydrophilic and hydrophobic properties of compound makes good antibacterial agent [48]. Compound3c with chlorine substituents showed the biggest zone of inhibition with 13 mm while3a with hydrogen showed the least zone of inhibition (8 mm).


## 4. Conclusions

A series of kojic esters2a–c and3a–c has been successfully synthesized and exhibited good antibacterial activity towards gram positiveS. aureus bacteria strain. Antibacterial activities of2a–c increased with the decrease in electronegativity of halogen substituent on chalcone with2c showing the highest inhibition, better than the ampicillin reference standard. Lipophilic properties of kojic ester bearing chalcone derivatives3a-b inhibited better antibacterial activity. Kojic ester5a–d bearing azobenzene derivatives showed good inhibition againstE. Colicompared to4a–d. The presence of C=O ester, N=N, and alkene chains has increased the lipophilic properties of of5a–d and disrupts the bacteria cell walls.



---

*Source: 1245712-2018-05-06.xml*